MSB 0.51% 97.0¢ mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-305

  1. 12,330 Posts.
    lightbulb Created with Sketch. 1103
    Hi,
    FDA cant dispute a compelling ARDS trial.
    Not with maybe 500,000 Americans getting put to the sword
    in the next few months.

    I dont see any end to this .At present there's only 1 in 400
    thats infected. Unfortunately that has a lot more scope to
    increase.

    SI wants an approval plain and simple.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.005(0.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.5¢ 98.5¢ 96.0¢ $2.168M 2.226M

Buyers (Bids)

No. Vol. Price($)
1 16000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 86854 7
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.